Aura Biosciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aura Biosciences Inc (AURA)
Aura Biosciences Inc stock price live, this page displays NASDAQ AURA stock exchange data. View the AURA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aura Biosciences Inc real time stock price chart below.
What Is the Aura Biosciences Inc Stock Price Today?
The Aura Biosciences Inc stock price today is 6.44.
What Is the Stock Symbol for Aura Biosciences Inc?
The stock symbol for Aura Biosciences Inc is ""AURA.""
What Stock Exchange Does Aura Biosciences Inc Trade On?
Aura Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Aura Biosciences Inc a Good Stock to Buy?
Determining whether Aura Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AURA quote. (ISIN: US05153U1079)
What Is the Aura Biosciences Inc Stock Price Today?
The Aura Biosciences Inc stock price today is 6.44.
What Is the Stock Symbol for Aura Biosciences Inc?
The stock symbol for Aura Biosciences Inc is ""AURA.""
What Stock Exchange Does Aura Biosciences Inc Trade On?
Aura Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Aura Biosciences Inc a Good Stock to Buy?
Determining whether Aura Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AURA quote. (ISIN: US05153U1079)
NASDAQ
Currency in USD
Fair Value
An estimate of a Aura Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.38
6.72
52 wk Range
4.35
12.38
AURA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
AURA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Aura Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.386.72
52 wk Range
4.3512.38
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AURA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Aura Biosciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
21.00
Upside
+226.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 13G Aura Biosciences For: 13 August
- Investing.com
- Form 8K Aura Biosciences Inc For: 13 August
- Investing.com
- Aura Biosciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 13G Aura Biosciences For: 13 August
- Investing.com
- Form 8K Aura Biosciences Inc For: 13 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Aura Biosciences Inc Company Profile
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmette–guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Aura Biosciences Inc SWOT Analysis
Bel-sar's Promise | Explore bel-sar's potential in treating choroidal melanoma and bladder cancer, with 80% of patients maintaining tumor control in Phase 2 trials |
Clinical Progress | Delve into Aura's ongoing Phase 3 CoMpass trial for choroidal melanoma and planned Phase 2 trials for choroidal metastasis and ocular surface cancers |
Market Opportunities | Discover Aura's estimated addressable market of 8,000 early-stage choroidal melanoma patients annually in the U.S. and EU, with potential peak sales of $1.5 billion |
Financial Outlook | Learn about Aura's strong financial position with $187 million in cash, providing runway into 2026, and a $23 price target from JMP Securities |
Compare AURA to Peers and Sector
Metrics to compare | AURA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAURAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | −4.6x | −0.6x | |
PEG Ratio | 0.40 | 0.01 | 0.00 | |
Price/Book | 2.3x | 2.4x | 2.6x | |
Price / LTM Sales | - | 8.4x | 3.3x | |
Upside (Analyst Target) | 223.1% | 205.1% | 38.7% | |
Fair Value Upside | Unlock | 1.2% | 5.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 21.00
(+226.09% Upside)
Earnings
Latest Release
Aug 13, 2025
EPS / Forecast
-0.47 / -0.47
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Aura Biosciences Trade On?
Aura Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Aura Biosciences?
The stock symbol for Aura Biosciences is "AURA."
What Is the Aura Biosciences Market Cap?
As of today, Aura Biosciences market cap is 417.45M.
What Is Aura Biosciences's Earnings Per Share (TTM)?
The Aura Biosciences EPS (TTM) is -1.95.
When Is the Next Aura Biosciences Earnings Date?
Aura Biosciences will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is AURA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aura Biosciences Stock Split?
Aura Biosciences has split 0 times.
How Many Employees Does Aura Biosciences Have?
Aura Biosciences has 108 employees.
What is the current trading status of Aura Biosciences (AURA)?
As of 28 Aug 2025, Aura Biosciences (AURA) is trading at a price of 6.44, with a previous close of 6.44. The stock has fluctuated within a day range of 6.38 to 6.72, while its 52-week range spans from 4.35 to 12.38.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.